Table 1.

Relationship between the clinical features of liver cancer and SLC25A11 expression.

Parameter	Variables	N	SLC25A11 expression				χ2	P value
			High	%	Low	%
Age	<55	117	54	27.84	63	35.39	2.122	0.145
	>=55	255	140	72.16	115	64.61
Sex	Female	121	64	32.82	57	32.02	0.003	0.957
	Male	252	131	67.18	121	67.98
Histological type	Fibrolamellar carcinoma	3	3	1.54	0	0.00	2.840	0.343
	Hepatocellular carcinoma	363	188	96.41	175	98.31
	Hepatocholangiocarcinoma (mixed)	7	4	2.05	3	1.69
Histologic grade	G1	55	35	18.23	20	11.36	9.400	0.023
	G2	178	100	52.08	78	44.32
	G3	123	52	27.08	71	40.34
	G4	12	5	2.60	7	3.98
Stage	I	172	100	55.25	72	42.86	8.161	0.039
	II	87	41	22.65	46	27.38
	III	85	36	19.89	49	29.17
	IV	5	4	2.21	1	0.60
T classification	T1	182	107	55.44	75	42.13	7.691	0.081
	T2	95	44	22.80	51	28.65
	T3	80	37	19.17	43	24.16
	T4	13	5	2.59	8	4.49
	TX	1	0	0.00	1	0.56
N classification	N0	253	130	66.67	123	69.49	1.797	0.404
	N1	4	1	0.51	3	1.69
	NX	115	64	32.82	51	28.81
M classification	M0	267	138	70.77	129	72.47	0.883	0.756
	M1	4	3	1.54	1	0.56
	MX	102	54	27.69	48	26.97
Radiation therapy	NO	340	177	97.25	163	98.19	0.051	0.821
	YES	8	5	2.75	3	1.81
Residual tumor	R0	326	174	91.58	152	86.36	4.121	0.210
	R1	17	7	3.68	10	5.68
	R2	1	1	0.53	0	0.00
	RX	22	8	4.21	14	7.95
Vital status	Deceased	130	56	28.72	74	41.57	6.218	0.013
	Living	243	139	71.28	104	58.43